Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic diversity and HIV detection by polymerase chain reaction.
Loussert-Ajaka I, Descamps D, Simon F, Brun-Vézinet F, Ekwalanga M, Saragosti S. Loussert-Ajaka I, et al. Among authors: saragosti s. Lancet. 1995 Sep 30;346(8979):912-3. doi: 10.1016/s0140-6736(95)92762-x. Lancet. 1995. PMID: 7564711 No abstract available.
HIV type 1 diversity in northern Paris, France.
Simon F, Loussert-Ajaka I, Damond F, Saragosti S, Barin F, Brun-Vézinet F. Simon F, et al. Among authors: saragosti s. AIDS Res Hum Retroviruses. 1996 Oct 10;12(15):1427-33. doi: 10.1089/aid.1996.12.1427. AIDS Res Hum Retroviruses. 1996. PMID: 8893050
HIV-1 group O sensitivity to antiretroviral drugs.
Descamps D, Collin G, Loussert-Ajaka I, Saragosti S, Simon F, Brun-Vézinet F. Descamps D, et al. Among authors: saragosti s. AIDS. 1995 Aug;9(8):977-8. AIDS. 1995. PMID: 7576340 No abstract available.
HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients.
Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Couroucé AM, Brun-Vézinet F, Simon F. Loussert-Ajaka I, et al. Among authors: saragosti s. Lancet. 1994 Jun 4;343(8910):1393-4. doi: 10.1016/s0140-6736(94)92524-0. Lancet. 1994. PMID: 7910884
HIV type 1 diversity and the reliability of the heteroduplex mobility assay.
Loussert-Ajaka I, Menu E, Apetrei C, Peeters M, Damond F, Mauclère P, Eberle J, Brengues C, Saragosti S, Barré-Sinoussi F, Brun-Vézinet F, Simon F. Loussert-Ajaka I, et al. Among authors: saragosti s. AIDS Res Hum Retroviruses. 1998 Jul 1;14(10):877-83. doi: 10.1089/aid.1998.14.877. AIDS Res Hum Retroviruses. 1998. PMID: 9671216
gag and env sequences of an A/G/H recombinant from a Zairian HIV type 1 isolate.
Duchet S, Letourneur F, Loussert-Ajaka I, Chaplain C, Gomas E, Brun-Vezinet F, Simon F, Saragosti S. Duchet S, et al. Among authors: saragosti s. AIDS Res Hum Retroviruses. 1997 Oct 10;13(15):1351-4. doi: 10.1089/aid.1997.13.1351. AIDS Res Hum Retroviruses. 1997. PMID: 9339853 No abstract available.
Sensitivity of screening kits for anti-HIV-1 subtype O antibodies.
Simon F, Ly TD, Baillou-Beaufils A, Fauveau V, De Saint-Martin J, Loussert-Ajaka I, Chaix ML, Saragosti S, Courouce AM, Ingrand D, et al. Simon F, et al. Among authors: saragosti s. AIDS. 1994 Nov;8(11):1628-9. doi: 10.1097/00002030-199411000-00021. AIDS. 1994. PMID: 7848605 Clinical Trial. No abstract available.
72 results